The complete 154-kbp linear double-stranded genomic DNA sequence of herpes simplex virus 2 (HSV-2), consisting of two extended regions of unique sequences bounded by a pair of inverted repeat elements, was published in 1998 and since then has been widely employed in a wide range of studies. Throughout the HSV-2 genome are scattered 150 microsatellites (also referred to as short tandem repeats) of 1-to 6-nucleotide motifs, mainly distributed in noncoding regions. Microsatellites are considered reliable markers for genetic mapping to differentiate herpesvirus strains, as shown for cytomegalovirus and HSV-1. The aim of this work was to characterize 12 polymorphic microsatellites within the HSV-2 genome by use of 3 multiplex PCR assays in combination with length polymorphism analysis for the rapid genetic differentiation of 56 HSV-2 clinical isolates and 2 HSV-2 laboratory strains (gHSV-2 and MS). This new system was applied to a specific new HSV-2 variant recently identified in HIV-1-infected patients originating from West Africa. Our results confirm that microsatellite polymorphism analysis is an accurate tool for studying the epidemiology of HSV-2 infections.
H
erpes simplex virus 2 (HSV-2), classified together with HSV-1 in the Alphaherpesvirinae subfamily, is a highly prevalent sexually transmitted infection worldwide. This virus shows prevalence rates ranging from 15 to 20% in Europe and the United States to 90% in some sub-Saharan African populations (1) . After primary infection, HSV-2 has the ability to establish lifelong latent infections in the host sensory sacral ganglia and may reactivate frequently, with clinical manifestations varying from asymptomatic viral shedding to painful genital vesicular lesions. The symptoms are usually self-limiting in immunocompetent individuals, whereas severe disseminated disease, sometimes debilitating, may occur in immunocompromised patients. HSV-2 may also cause neonatal herpes after vertical transmission from mother to newborn (2, 3) .
The HSV-2 genome consists of a linear double-stranded genomic DNA sequence of 154 kbp (strain HG52; GenBank accession no. Z86099), composed of two extended regions of unique sequences (i.e., unique long [U L ] and unique short [U S ]) bounded by a pair of terminal repeat and internal inverted repeat elements and over 74 open reading frames (4, 5) . The occurrence of endogenous reinfection or superinfection in genital HSV-2 infections has been previously documented using genomic analysis, i.e., restriction fragment length polymorphism (RFLP) analysis or multilocus sequencing assays based on the analysis of several DNA regions, yielding specific patterns of subgenomic products to distinguish unrelated HSV-2 strains (6) (7) (8) . The main advantage of RFLP analysis over PCR-based and sequencing processes is that no prior nucleotide sequence data are required. However, this method remains relatively tedious to perform (9, 10) . Herpesvirus genomes are quite stable and exhibit limited sequence variation (11) . However, they have been shown to contain several sites with short tandem repeats of 1-to 6-nucleotide motifs known as microsatellites. Homopolymers of at least 6 consecutive nucleotides are the most abundant class of microsatellites in all viral genomes examined so far (12) . Microsatellites are further classified as perfect (identical repeats), interrupted (repeats interrupted by point mutations), or compound (adjacent perfect microsatellites with different motifs) microsatellites (13, 14) . Genetic variation within these elements has been reported to explain microsatellite instability through recombination processes or DNA polymerase slippage during DNA replication (15, 16) . As hypervariable genomic regions, microsatellites have proven to be useful as molecular markers for epidemiological studies of viral strain diversity. To date, the identification and genetic mapping of polymorphic microsatellite markers have been reported to have high discriminatory power and high throughput for human cytomegalovirus (HCMV), HSV-1, and HIV infections (17) (18) (19) . The aims of this work were to establish the map and to characterize microsatellites within the full-length genome of HSV-2 and to confirm that the analysis of microsatellite polymorphism constitutes an accurate tool for the mapping of molecular profiles of HSV-2 clinical isolates in different epidemiological situations.
MATERIALS AND METHODS

Viral strains and cells.
A total of 56 HSV-2 clinical isolates and 2 laboratory strains (gHSV-2 and MS) were included in the present study. The HSV-2 isolates were selected retrospectively from viral isolates obtained in cell culture and stored in the laboratory between 2005 and 2012, in order to obtain a range of viruses collected from both immunocompetent and immunosuppressed (mainly HIV-infected) patients and recovered from different body sites (i.e., anal, genital, buttock, ear, bronchoalveolar lavage fluid, and back specimens). This selection allowed comparison of isolates from epidemiologically unrelated patients (isolates 1 to 43), sequential isolates corresponding to recurrent episodes in the same individuals, for which resistance to antivirals was investigated (isolates 44 to 46), and isolates recently described and belonging to a new HSV-2 genetic variant (designated HSV-2v; isolates 47 to 50) (20) . All HSV-2 isolates were recovered from patients originating from European countries (mainly France) except for isolates 47 to 50, which were obtained from patients from West Africa (20) . Both HSV-2 clinical isolates and laboratory strains were propagated in Vero cell cultures, as described previously (21) . The determination of HSV type was performed by means of a specific realtime PCR (artus HSV-1/2 kit; Qiagen, Courtaboeuf, France) or an immunofluorescence assay using type-specific monoclonal antibodies (Trinity Biotech Plc, Wicklow, Ireland). The susceptibilities to acyclovir (ACV) and foscarnet (FOS) of HSV-2 laboratory strains and clinical isolates were determined by plaque reduction assays and genotypic assays, as described previously (21) . Viruses were considered to be resistant at 50% effective concentration (EC 50 ) values of Ն7 M and 330 M for ACV and FOS, respectively (21, 22) .
Identification of HSV-2 microsatellites by computer study. Microsatellite identification within the whole genome of HSV-2 reference strain HG52 (GenBank accession no. Z86099) was performed using the MSatFinder program (5) (http://bioinformatics.rri.sari.ac.uk/bioinformatics /docs/documentation/msatfinder/msatfinder_manual.html). Results included only short microsatellites with at least four trinucleotide, five dinucleotide, or nine mononucleotide repeat units, as described previously (18, 23) .
HSV-2 microsatellite characterization by conventional sequencing. Viral DNA was extracted from 200 l of viral stock (laboratory strains and clinical isolates) by using the QIAamp DNA blood minikit (Qiagen) or the MagNA Pure compact system (Roche Diagnostics, Meylan, France), according to the manufacturer's instructions. The purified nucleic acids were eluted in 100 l of elution buffer and stored at Ϫ20°C until further analysis. PCR-amplified DNA fragments obtained with 19 different PCR systems encompassing reiterated regions corresponding to 22 microsatellites (including 6 trinucleotide, 3 dinucleotide, and 13 mononucleotide repeat units) were used to classify each microsatellite as monomorphic or polymorphic and to evaluate the number of distinct variants (Table 1) . Primer design was performed using Primer3 software (24) . Singleplex PCRs were performed with 10 l of DNA extract using the proofreading enzyme Expand High Fidelity (Roche Diagnostics), in a mixture containing 10ϫ buf- fer, 1.5 mM MgCl 2 , 800 M deoxynucleoside triphosphates (dNTPs), and 300 M forward and reverse primers. PCR product sizes ranged from 138 to 616 bp (Table 1) . Amplification conditions included an initial denaturation step of 2 min at 96°C, 45 cycles of 1 min at 96°C, 1 min at 52.5°C, and 2 min at 68°C, and a final extension step of 2 min at 68°C. All PCRs were performed using an Eppendorf thermal cycler (Eppendorf, Le Pecq, France). Amplified products were sequenced with the Prism BigDye Terminator cycle sequencing ready reaction kit (Applied Biosystems, Courtaboeuf, France) and were analyzed with an ABI Prism 3730 automated sequencer (Applied Biosystems). All nucleotide sequences were compared with that of HSV-2 reference strain HG52 (GenBank accession no. Z86099) using SeqScape v2.5 software (5).
HSV-2 microsatellite characterization by length polymorphism analysis. Twelve polymorphic microsatellites (corresponding to 9 loci) localized throughout the complete genome of HSV-2, i.e., M20, M28, M37, M38, M43, M50, M51, M55, M63, M64, M72, and M125, were selected for length polymorphism analysis ( Fig. 1 and Table 1 ). This choice of microsatellite markers was based on both their polymorphic character and the size of the generated amplicons (to avoid any potential size range overlapping), in order to yield multiplex sets that were as discriminative as possible (Table 1) . Three multiplex PCR systems were developed to amplify these microsatellites. Forward primers of each set were labeled with 6-carboxyfluorescein dye at the 5= end. Three different primer pair combinations were tested to identify the optimal combination. Once suitable multiplex PCR protocols had been defined, primer pair concentrations were adapted as necessary to obtain relatively equal amplicon productions, with visualization under UV light on agarose gels stained with ethidium bromide. Multiplex PCRs were carried out using an Eppendorf thermal cycler (Eppendorf) with a reaction mixture containing 10 l of DNA extract, the proofreading enzyme Expand High Fidelity (Roche Diagnostics), 10ϫ buffer, 1.5 mM MgCl 2 , 800 M dNTPs, and forward and reverse primers with the following concentrations: 800 nM M20 primers, 800 nM M72 primers, and 1,280 nM M37 and M38 primers for multiplex 1; 800 nM M28 primers, 800 nM M50 and M51 primers, and 800 nM M55 primers for multiplex 2; 800 nM M43 primers, 1,200 nM M63 and M64 primers, and 1,280 nM M125 primers for multiplex 3. All multiplex PCRs were performed with the same cycling conditions, namely, an initial denaturation step of 2 min at 96°C, 45 cycles of 1 min at 96°C, 1 min at 52.5°C, and 2 min at 68°C, and a final extension step of 2 min at 68°C. One microliter of the amplified multiplex PCR products was diluted with sterile water (1:200) and analyzed with an ABI Prism 3730 automated capillary sequencer (Applied Biosystems) with the GeneScan 600LIZ internal size standard. Amplicon sizes were scored using Peak Scanner v.1.0 software (Applied Biosystems). In order to assess the specificity of this multiplex assay, labeled amplicons obtained from single PCRs were secondarily mixed together and analyzed according to the protocol described below for the first 13 HSV-2 clinical isolates. Each isolate was tested by multiplex PCRs and analyzed in triplicate (intraassay precision) and in independent assays (interassay variability).
Neighbor-joining phylogenetic tree and principal component analysis. The genetic relationships among HSV-2 isolates based on the frequencies of amplicon sizes at the different microsatellite loci were analyzed using two different approaches. First, phylogenetic trees were constructed using the neighbor-joining clustering method, and the genetic divergence between HSV-2 isolates was calculated according to genetic distances using Population 1.2.32 software (http://www .bioinformatics.org/project/?group_idϭ84). Second, as an alternative approach to represent the genetic relationships among HSV-2 isolates, principal component analysis (PCA) was applied using gene frequencies at the loci to represent the data on a two-dimensional map and to identify trends. A scattergram of the score data was examined for visualization of the geometric relationships among the HSV-2 isolates. PCA using microsatellite data was performed using the XLSTAT program (XLSTAT, New York, NY).
RESULTS
Microsatellite mapping within the HSV-2 complete genome.
In silico analysis allowed the identification of 150 different microsatellites (66 mononucleotide, 11 dinucleotide, and 73 trinucleotide repeats), numbered HSV-2 M1 to HSV-2 M150, which were located predominantly within noncoding regions of the HSV-2 genome (strain HG52; GenBank accession no. Z86099). Indeed, 129 microsatellites were found to be distributed in intergenic or noncoding inverted repeat regions, whereas 21 were localized in open reading frames (Fig. 1) . The maximal numbers of repeat units were 12 and 8 for dinucleotide [M30-(TC) 12 and M78-(GA) 12 ] and trinucleotide [M116-(TCG) 8 and M140-(ACG) 8 ] motifs, respectively. As expected, poly(C/G) tracts (89.4%) were more abundant than poly(A/T) mononucleotide repeat sequences, because HSV-2 genomes demonstrate GC contents of around 70%. M125-(G) 19 has been identified as the longest mononucleotide tract within the HSV-2 reference sequence. All of the microsatellites were perfect microsatellites except for M25/M26, M37/M38, M78/M79, and M82/M83, which were compound microsatellites ( Fig. 1 and Table 1 ).
Characterization of HSV-2 microsatellites. Twenty-two microsatellites were selected and surveyed using 19 PCR systems in order to perform length polymorphism analyses of a set of 2 laboratory strains (gHSV-2 and MS) and 13 clinical isolates (isolates 1 to 13). These microsatellites were localized along the HSV-2 genome, mainly within noncoding regions, and were composed of mononucleotide, dinucleotide, and trinucleotide units ( Table 2) . Sequence analyses allowed the identification of 7 monomorphic Reference strain HG52  184  138  444  163  498  218  420  364  488  Laboratory strains  gHSV-2  ACV-S/FOS-S 181  132  440  157  493  210  406  360  469  MS  ACV-S/FOS-S 179  132  435  159  494  200  418  361  470   Clinical isolates  1  Genital  NA  ND  180  133  442  157  493  214  409  361  480  2  Anal  NA  ND  180  132  442  157  493  209  419  360  472  3  Genital  IC  ND  182  132  439  157  493  211  413  362  469  4  Genital  NA  ND  181  132  440  157  490  211  415  361  468  5  Genital  Pregnancy ND  180  132  438  157  494  209  421  361  474  6  Genital  Elderly  ND  181  132  440  159  494  200  412  362 IC  ND  180  133  437  157  494  211  420  362  473  25  Buttock  IC  ND  182  132  438  159  493  198  408  360  475  26  Buttock  IC  ND  182  132  438  159  494  211  414  363  475  27  Genital  IC  ND  180  136  440  157  491  211  415  361  477  28  Genital  IC  ND  181  135  440  159  497  197  416  359  470  29  Anal  IC  ND  180  132  439  157  492  198  416  361  470  30  Genital  IC  ND  181  136  442  157  493  209  415  359  475  31  Genital  IC  ACV-S  181  132  441  157  493  210  416  364  470  32  Genital  HIV  ND  180  133  439  159  490  200  413  361  474  33  Buttock  HIV  ND  181  132  438  159  489  202  417  360  476  34  Genital  HIV  ND  179  132  440  159  492  201  415  361  469  35  Genital  HIV  ND  181  132  439  159  493  209  415  362  471  36  Anal  HIV  ND  183  136  440  157  480  196  411  356  466  37  Genital  HIV  ND  179  132  437  159  493  199  411  362  471  38  Genital  HIV  ND  180  132  439  159  494  200  416  362  469  39  Buttock  HIV  ND  179  132  438  158  493  213  412  360  468  40  Buttock  HIV  ND  182  133  439  157  492  211  420  363  473  41  Genital  HIV  ND  180  134  439  157  490  212  413  360  475  42  Genital  HIV  ND  179  132  438  158  492  214  414  361  475  43  Ear  HIV  ND  180  132  439  157  493  209  415  360  471 (Table 1 ). The laboratory strains gHSV-2 and MS showed distinct nucleotide patterns concerning these target repeats, in comparison with the 13 clinical isolates ( Table 2) .
Multiplex assay for differentiation of HSV-2 clinical isolates.
For the rapid mapping of genetic profiles of HSV-2 clinical isolates by length polymorphism analysis, 3 distinct multiplex PCR systems, amplifying 12 polymorphic microsatellites, were developed by mixing primer sets as follows: (i) M20, M72, and M37/M38, (ii) M28, M50/M51, and M55, and (iii) M43, M63/M64, and M125. Each HSV-2 clinical isolate was thereby characterized by its own microsatellite haplotype corresponding to the combination of the PCR product lengths obtained with the 3 multiplex assays (Fig. 2) . For the 2 laboratory strains and the 13 isolates investigated above, the numbers of size variants ranged from 5 to 13 repeats (mean, 7.7 repeats) ( Table 2 ). As expected, the microsatellite haplotypes for the clinical isolates obtained from distinct individuals were all different ( Table 1 ). The interassay reproducibility was evaluated by performing the multiplex PCRs in triplicate with a gHSV-2 laboratory strain sample in 10 independent reactions. No variation in haplotypes was observed. The investigation of microsatellite haplotype stability after each of 16 passages of the gHSV-2 laboratory strain and 2 clinical isolates (isolates 14 and 15) ( Table  2) in Vero cell cultures detected minor variations over time (2 months) within microsatellite M63/M64 only, as illustrated in Table 3. These data emphasize the stability of HSV-2 microsatellites during viral replication. This strategy, based on the analysis of 12 combined microsatellites, yields, in theory, a discriminatory power allowing the identification of at least 10 6 to 10 7 different haplotypes, considering the numbers of variants described for each of these microsatellites ( Table 1) . As a whole, the multiplex assays in combination with length polymorphism analyses permitted rapid accurate identification of HSV-2 strains.
Differentiation of HSV-2 clinical isolates. The multiplex PCR method was applied to characterize HSV-2 clinical isolates corresponding to different epidemiological situations, i.e., (i) isolates from epidemiologically unrelated patients (isolates 14 to 43), (ii) isolates corresponding to recurrent episodes in the same individuals, for which HSV-2 resistance to antivirals was investigated (isolates 44 to 46), and (iii) isolates recently described and considered new HSV-2 genetic variants (designated HSV-2v; isolates 47 to 50) ( Table 2 ). As observed previously for the first 13 clinical isolates investigated, the microsatellite haplotypes for 30 isolates recovered from unrelated patients were all different. Microsatellite haplotypes for recurrent HSV-2 isolates that exhibited drug resistance (isolates 44 and 46) remained quite stable over time despite variations in antiviral susceptibility. Thus, only microsatellites M37/M38, M55, M63/M64, M72, and M125 exhibited length polymorphisms ranging from 1 to 10 bp. Of note, the widest polymorphism was observed for M63/M64 (Table 2) . Microsatellite haplotypes for HSV-2v isolates appeared to be more variable than those for classic HSV-2 isolates (Table 2) .
In order to illustrate the results for the HSV-2 haplotypes obtained for all laboratory strains (n ϭ 2) and clinical isolates (n ϭ 56) presented above, microsatellite allele frequencies were used to generate an unrooted phylogenetic tree using the neighbor-joining algorithm and PCA was performed (Fig. 3 and 4) . The results of both analyses showed that all HSV-2 strains were genetically Laboratory strain gHSV-2  0  181  132  440  157  493  210  406  360  469  30  181  132  440  157  493  210  404  360  469  60  181  132  440  157  493  210  406  360  469  Clinical isolates  14  0  184  133  439  159  493  225  422  361  475  30  184  133  439  159  493  225  423  361  475  60  184  133  439  159  493  225  422  361  475  15  0  179  133  438  157  493  212  421  361  479  30  179  133  438  157  493  212  422  361  479  60  179  133  438  157  493  212  421  361  479 distinguishable and converged to the lack of evidence for a close genetic relationship among them. On the PCA chart, the laboratory strains gHSV-2 and MS clustered together with the majority of HSV-2 clinical isolates. However, reference strain HG52 and isolates 20 and 36 were distinguishable from the rest of the grouped isolates. Among the newly described HSV-2v isolates, only isolate 48 did not cluster together with the majority of HSV-2 isolates.
DISCUSSION
This study, aiming to describe and to characterize HSV-2 short microsatellites, provides for the first time a map of numerous microsatellites across the whole viral genome, characterized by a high level of length polymorphism. HSV-1 and HSV-2, two closely related viruses belonging to the Simplexvirus genus in the Alphaherpesvirinae subfamily, constitute important human pathogens with different infection profiles. HSV-1 often is associated with orolabial lesions, whereas HSV-2 primarily causes genital infections. Despite their high degree of genomic identity, the two viruses do not have similar microsatellite features in terms of abundance, density, and motifs. Deback et al. (18) previously identified 79 microsatellites throughout the HSV-1 genome, whereas this work reports 150 microsatellites within the HSV-2 genome (using the same filtering options for research), located mainly in noncoding regions and with overrepresentation of homopolymeric repeats of guanosine or cytosine ( Fig. 1 and Table  1 ). The latter point may be attributable to the high GC content (around 70%) of the HSV-2 genome (25, 26) . Microsatellites among viruses have higher mutation rates than do the eukaryotic DNA sequences and therefore are thought to be the source of genetic diversity (27) . Moreover, these microsatellites seem to play important roles in the evolution of viruses, in terms of epidemiology, pathophysiology, or environmental con-
FIG 3
Phylogenetic tree based on 12 HSV-2 microsatellites, depicting the genetic relationships among the 56 clinical isolates and 2 laboratory strains investigated. The neighbor-joining relationship unrooted tree was constructed based on Nei's distance matrix derived from microsatellite allele frequencies (37) . The numbers of HSV-2 isolates, presented in Table 1 , are indicated beside the corresponding branches. The solid bar beside the phylogenetic tree indicates length based on similarity. The predicted haplotype of HSV-2 reference strain HG52 (GenBank accession number Z86099) was included, as well as the haplotypes of laboratory strains gHSV-2 and MS. ditions. Length variations within microsatellites have been implicated in the virulence of avian influenza virus and encephalomyocarditis virus (28, 29) . Regarding herpesviruses, genetic variations of microsatellites within the pseudorabies virus genome have been shown to be involved in attenuation of the vaccine strain (30) . Microsatellite markers are also useful for epidemiological studies, as previously reported for the precise characterization of HCMV or HSV-1 strains (18, 19, 23, 31) . Furthermore, telomeric repeats located in the human herpesvirus 6 genome have been shown to facilitate viral DNA integration into host cell chromosomes (32, 33) . Mutations in HSV-2 intragenic microsatellites have been reported to have clinical impact. Thus, HSV resistance to ACV may result from insertions or deletions in homopolymers located in the UL23 gene (encoding thymidine kinase) (34) , and variations in the human antibody response to HSV may be associated with insertions or deletions in homopolymers located in the US4 gene (encoding glycoprotein G) (35) . As a whole, the characterization of microsatellites within viral genomes may improve our knowledge regarding the epidemiology and pathogenesis of viruses.
In this study, a new multiplex assay was developed in order to differentiate HSV-2 isolates according to polymorphic microsatellite markers. In the manner of multiplex assays used for HSV-1 strains (18, 31) , microsatellite analysis is shown to be a reliable and highly discriminative method. Microsatellite length variations are probably generated by DNA polymerase slippage during DNA replication or recombination processes (15) . To minimize nonspecific artifacts of PCR amplification, a proofreading Taq polymerase was used in the multiplex assay reported here. The shortterm stability of microsatellite profiles was assessed by monitoring 2 distinct clinical isolates (isolates 14 and 15) and one HSV-2 laboratory strain (gHSV-2) propagated in vitro in Vero cell cultures for 8 weeks. Our multiplex system demonstrated that HSV-2 strains can undergo microevolutionary events for particular microsatellites without effects on antiviral susceptibility. The phylogenetic reconstructions using microsatellite haplotypes demonstrated a clear distinction between HSV-2 strains. Indeed, all clinical isolates exhibited distinct patterns, with the exception of isolates recovered from the same patient ( Fig. 3 and Table 2 ). This study demonstrates the potential of microsatellites to provide accurate polymorphic molecular markers that can be used to address medical questions regarding HSV-2, such as potential nosocomial infections, mother-to-child transmission, multiple recurrent infections, or exogenous reinfection.
Among the 12 microsatellites used in the multiplex assay, M63/ M64 seemed to show a higher level of variation. This intergenic microsatellite is located within a noncoding region, between the UL37 gene (encoding a tegument phosphoprotein) and the UL38 gene (encoding the capsid protein VP19C). This is in accordance with a previous result indicating that this region of the HSV-2 genome exhibits a higher degree of variation than do others (36) . However, the reasons for this higher level of polymorphism remain unknown.
Recently, we reported the description of a new genetic variant, designated HSV-2v, that was isolated from HIV-infected African patients and exhibited high levels of divergence within the DNA polymerase (UL30) and glycoprotein G (US4) genes, in comparison with classic HSV-2 isolates (20) . Phylogenetic analysis based on UL30 and US4 sequences demonstrated that HSV-2v isolates clustered in a genetic group distinct from that of classic HSV-2 isolates. Preliminary data indicated that HSV-2v might represent zoonosis or might result from a recombination mechanism (20) . In this study, the analysis of microsatellite polymorphisms did not reveal any specific clustering profile for HSV-2v isolates. Thus, the global principal component analysis demonstrated that only one of these viruses (isolate 48) was clearly distinguishable from the classic HSV-2 isolates (Fig. 4) . Further studies using next-generation sequencing technology are now warranted to assess the origin of this new variant.
In conclusion, the analysis of microsatellite polymorphisms using a newly developed multiplex PCR assay allowed the precise characterization of HSV-2 isolates. The promising preliminary data presented herein should have implications for further epidemiological investigations (e.g., to distinguish unrelated strains, to demonstrate superinfection rather than reactivation, or to demonstrate nosocomial infections) and HSV-2 evolution studies, as reported previously for HSV-1 and HCMV (18, 19, 23, 31) .
